Teva Pharmaceutical Industries Ltd., the troubled Israeli manufacturer of generic drugs, will be moving its US headquarters from Pennsylvania to New Jersey, lured by 10-year, $40 million tax incentive plan.
{iframe}https://www.timesofisrael.com/israels-teva-to-move-us-hq-from-pennsylvania-to-new-jersey/{/iframe}